Erratum: Changes in Ocular Blood Flow after Ranibizumab Intravitreal Injection for Diabetic Macular Edema Measured Using Laser Speckle Flowgraphy (BioMed Research International (2020) 2020 (9496242) DOI: 10.1155/2020/9496242)

Lisa Toto, Federica Evangelista, Pasquale Viggiano, Emanuele Erroi, Giada D'Onofrio, Daniele Libertini, Annamaria Porreca, Rossella D'Aloisio, Mariacristina Parravano, Luca Di Antonio, Marta Di Nicola, Rodolfo Mastropasqua

Research output: Contribution to journalComment/debatepeer-review

Abstract

In the article titled Changes in Ocular Blood Flow after Ranibizumab Intravitreal Injection for Diabetic Macular Edema Measured Using Laser Speckle Flowgraphy [1], there was an error in the corresponding author’s name in the article. This is corrected as shown below. Correspondence should be addressed to Federica Evangelista federica.evan@hotmail.com. Also, the brand of the instrument used was listed incorrectly in the Materials and Methods and Procedures section; it has now been changed to NIDEK Co., LT Gamagori, Aichi, Japan.

Original languageEnglish
Article number6219089
JournalBioMed Research International
Volume2020
DOIs
Publication statusPublished - 2020

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)
  • Immunology and Microbiology(all)

Fingerprint Dive into the research topics of 'Erratum: Changes in Ocular Blood Flow after Ranibizumab Intravitreal Injection for Diabetic Macular Edema Measured Using Laser Speckle Flowgraphy (BioMed Research International (2020) 2020 (9496242) DOI: 10.1155/2020/9496242)'. Together they form a unique fingerprint.

Cite this